1. Orange Book: Approved drug products with therapeutic equivalence evaluations. U.S. Food and Drug Administration website. http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm. Updated May 13, 2015. Accessed May 14, 2015.
  2. Gablofen [package insert]. Hazelwood, MO: Mallinckrodt Brand Pharmaceuticals, Inc.; 2015.
  3. Use of unapproved drugs with the SynchroMed® Implantable Infusion Pump. Medtronic for Healthcare Professionals website. https://professional.medtronic.com/pt/neuro/idd/ind/product-advisories/NOVEMBER-2012-SYNCHII. Published November 2012. Accessed April 4, 2014.
  4. Lioresal [package insert]. Minneapolis, MN: Medtronic, Inc; 2013.
  5. Mullarkey T. Pharmacy compounding of high-risk level products and patient safety. Am J Health-Syst Pharm. 2009;66(17 suppl 5):S4-S13.
  6. Eighty percent larger volume screening dose syringe calculation. April 15, 2014. Data on file. Mallinckrodt Inc.
  7. 2015 table of drugs. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services website. http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Downloads/2015-Table-of-Drugs-.pdf. Updated October 8, 2014. Accessed May 14, 2015.